AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2024
Jun 7, 2024
34576_dirs_2024-06-06_b8cb5601-49e4-4331-9bbd-a383b29ad218.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2024-06-05
Reporting Person: Blaug Suzanne (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-05 | Stock Option (Right to Buy) | $1.21 | A | 70000 | Acquired | 2034-06-04 | Common Stock (70000) | Direct |
Footnotes
F1: Options vest on the earlier of June 16, 2025 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.
More from FIBROGEN INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 15
Regulatory Filings
2026
Jun 9
Delisting Announcement
2026
Apr 9
Call Transcript
2026
Mar 16
Call Transcript
2026
Mar 11
Call Transcript
2026
Feb 26
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Board/Management Information
2026
Jan 7
Director's Dealing
2025
Dec 9